This impromptu episode was created to hopefully set your mind at ease. As PWDs are flooded with stories on social media concerning the fear of an insulin shortage or the disruption of diabetes supplies, I felt compelled to act. Even though most companies have issued statements reassuring people living with diabetes that everything would be okay, I wanted to hear it for myself from the company leaders. Continue reading →
DreaMed Diabetes, a leader in AI solutions for personalized diabetes management and the company behind the first artificial pancreas technology recently launched Advisor Pro software. This software can analyze glucose and insulin data in seconds and advise on an optimal treatment plan including basal rate, carb ratio, insulin sensitivity factor, and personal management tips. The Advisor Pro also allows remote clinic visits and frequent titration changes.
Steady Health is the first full-service digital diabetes clinic in the US. Their services combine the power of continuous glucose monitors and the convenience of telemedicine to deliver a new type of care to patients. You can see an endocrinologist from home and get ongoing care and support from a team of diabetes specialists.
While on the road with the Real Life Diabetes podcast in Scottsdale, I had the pleasure of having dinner with Paloma Kemak (aka Glitter Glucose). Her story is very different from mine, but her diagnosis and overall mindset is entertaining and up-lifting. Paloma’s energy and ability to laugh while sharing her story is contagious and inspiring to PWDs from across the globe.
I came across a recent article, The Truth About the Ice Bucket Challenge by VOX.com, that sparked a bit of anger. As someone in the non-profit world, charitable gifts are a HUGE component to the success of your organization or cause, and in my industry we have to be transparent as to what the donation will be used for (capital improvements, programming, general operation expenses, etc). The recent ALS challenge and the statistics from this article brought that gut wrenching question to the surface – where is this money going? Will it focus on finding a cure or just advancing methods/medications to treat the disease. Both are very important, but my blood begins to boil knowing that a few companies actually benefit from the focus being on medications instead of a cure. Continue reading →